Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, announced today a growth investment in Sabai Global (“Sabai”), a Chesterfield, MO based provider of regulatory review and biosafety consulting services to pharmaceutical sponsors, CROs, academic health systems, and clinical research site networks. Sabai Global’s three subsidiaries, Clinical Biosafety Services (“CBS”), Shield Consulting (“Shield”), and Castle IRB (“Castle”) provide a suite of complementary services that facilitate regulatory approval and accelerate clinical research timelines for drug development.
Read the full article: Thompson Street Capital Partners Completes Growth Investment in Sabai Global //
Source: https://www.businesswire.com/news/home/20230206005158/en/Thompson-Street-Capital-Partners-Completes-Growth-Investment-in-Sabai-Global